Annual CFI
-$5.90B$4.12B-232.20%
Summary
- Current Value
- As of today, GSK annual cash from investing is -$5.90B, down -232.20% on
- Historical Performance
- GSK annual cash from investing is up +45.81% over the past 3 years, down -319.58% over the past 5 years
- All-Time High Comparison
- GSK annual cash from investing is currently -165.05% below its historical high of $9.06B set on
- 3-Year Low Comparison
- GSK annual cash from investing is +45.81% above its 3-year low of -$10.88B reached on an earlier date
- Sector Comparison
- GSK annual cash from investing is higher than 0.71% of companies in Healthcare sector
Cash From Investing Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Investing | -$5.90B | -232.2% | +45.8% | -319.6% | -91.7% | |
| Quarterly Cash From Investing | -$10.48B | -386.8% | -1464.7% | -535.2% | -2374.6% | |
| TTM Cash From Investing | -$16.62B | -174.0% | -441.5% | -717.6% | -3071.7% | |
| Price | $49.13 | +4.8% | +43.8% | +12.6% | +11.4% | |
| Annual Cash From Operations | $9.62B | +23.7% | +17.9% | -1.9% | +1.4% | |
| Annual Cash From Financing | -$3.96B | +24.4% | -293.4% | +66.7% | +46.5% | |
| Annual CAPEX | $3.93B | +3.2% | +41.4% | +37.0% | +55.9% | |
| Annual Free Cash Flow | $5.69B | +43.2% | +5.8% | -17.9% | -18.3% | |
| Annual Total Assets | $82.21B | +10.4% | +13.6% | -25.2% | +24.3% |
Cash From Investing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$1.77B | -232.2% | |
| 5Y | $2.69B | N/A | -319.6% |
| All | $9.06B | -165.1% |
Cash From Investing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$10.88B | N/A | +45.8% |
| 5Y | -$10.88B | +45.8% | |
| All | -$14.62B | +59.7% |
Cash From Investing History
FAQ
- What is the current annual cash from investing of GSK?
- As of today, GSK annual cash from investing is -$5.90B
- What is 1-year change in GSK annual cash from investing?
- GSK annual cash from investing is down -232.20% year-over-year
- What is 3-year change in GSK annual cash from investing?
- GSK annual cash from investing is up +45.81% over the past 3 years
- How far is GSK annual cash from investing from its all-time high?
- GSK annual cash from investing is currently -165.05% below its historical high of $9.06B set on December 31, 2015
- How does GSK annual cash from investing rank versus sector peers?
- GSK annual cash from investing is higher than 0.71% of companies in Healthcare sector
- When is GSK next annual earnings release?
- The next annual earnings release for GSK is on
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
Quarterly CFI
-$10.48B$9.30B-790.84%
Summary
- Current Value
- As of today, GSK quarterly cash from investing is -$10.48B, down -790.84% on
- Historical Performance
- GSK quarterly cash from investing is down -386.79% year-over-year, down -1464.69% over the past 3 years
- All-Time High Comparison
- GSK quarterly cash from investing is currently -198.25% below its historical high of $10.66B set on
- 3-Year Low Comparison
- GSK quarterly cash from investing is at its 3-year low
- Sector Comparison
- GSK quarterly cash from investing is higher than 0.10% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Investing | -$10.48B | -790.8% | -386.8% | -1464.7% | -535.2% | |
| Annual Cash From Investing | -$5.90B | – | -232.2% | +45.8% | -319.6% | |
| TTM Cash From Investing | -$16.62B | -100.4% | -174.0% | -441.5% | -717.6% | |
| Price | $49.13 | -5.0% | +4.8% | +43.8% | +12.6% | |
| Quarterly Cash From Operations | $3.77B | +11.5% | +24.5% | +35.8% | +7.7% | |
| Quarterly Cash From Financing | $6.40B | +351.6% | +474.4% | +395.2% | +441.5% | |
| Quarterly CAPEX | $719.73M | -17.7% | -40.2% | +12.2% | -56.8% | |
| Quarterly Free Cash Flow | $3.05B | +21.6% | +67.2% | +42.8% | +66.0% | |
| Quarterly Total Assets | $95.25B | +16.2% | +15.3% | +28.2% | -10.2% |
Quarterly Cash From Investing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$1.18B | -790.8% | |
| 3Y | $924.65M | -1233.2% | |
| 5Y | $924.65M | -1233.2% | |
| All | $10.66B | -198.3% |
Quarterly Cash From Investing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$10.48B | at low | |
| 3Y | -$10.48B | at low | |
| 5Y | -$10.48B | at low | |
| All | -$13.29B | +21.2% |
Quarterly Cash From Investing History
FAQ
- What is the current quarterly cash from investing of GSK?
- As of today, GSK quarterly cash from investing is -$10.48B
- What is GSK quarterly cash from investing most recent change?
- GSK quarterly cash from investing was down -790.84% on September 30, 2026
- What is 1-year change in GSK quarterly cash from investing?
- GSK quarterly cash from investing is down -386.79% year-over-year
- How far is GSK quarterly cash from investing from its all-time high?
- GSK quarterly cash from investing is currently -198.25% below its historical high of $10.66B set on March 31, 2015
- How does GSK quarterly cash from investing rank versus sector peers?
- GSK quarterly cash from investing is higher than 0.10% of companies in Healthcare sector
- When is GSK next earnings release?
- The next earnings release for GSK is on
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
TTM CFI
-$16.62B$8.33B-100.36%
Summary
- Current Value
- As of today, GSK TTM cash from investing is -$16.62B, down -100.36% on
- Historical Performance
- GSK TTM cash from investing is down -174.02% year-over-year, down -441.47% over the past 3 years
- All-Time High Comparison
- GSK TTM cash from investing is currently -278.15% below its historical high of $9.33B set on
- 3-Year Low Comparison
- GSK TTM cash from investing is at its 3-year low
- Sector Comparison
- GSK TTM cash from investing is higher than 0.29% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Investing | -$16.62B | -100.4% | -174.0% | -441.5% | -717.6% | |
| Annual Cash From Investing | -$5.90B | – | -232.2% | +45.8% | -319.6% | |
| Quarterly Cash From Investing | -$10.48B | -790.8% | -386.8% | -1464.7% | -535.2% | |
| Price | $49.13 | -5.0% | +4.8% | +43.8% | +12.6% | |
| TTM Cash From Operations | $11.39B | +7.0% | +16.8% | +90.3% | +16.0% | |
| TTM Cash From Financing | $5.17B | +276.4% | +226.5% | +257.3% | +160.3% | |
| TTM CAPEX | $3.54B | -12.0% | -13.8% | +25.5% | -12.5% | |
| TTM Free Cash Flow | $7.85B | +18.5% | +39.0% | +148.0% | +36.0% | |
| Quarterly Total Assets | $95.25B | +16.2% | +15.3% | +28.2% | -10.2% |
TTM Cash From Investing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$6.07B | N/A | -174.0% |
| 3Y | $292.30M | -5786.5% | |
| 5Y | $292.30M | -5786.5% | |
| All | $9.33B | -278.1% |
TTM Cash From Investing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$16.62B | at low | |
| 3Y | -$16.62B | at low | |
| 5Y | -$16.62B | at low | |
| All | -$19.30B | +13.9% |
TTM Cash From Investing History
FAQ
- What is the current TTM cash from investing of GSK?
- As of today, GSK TTM cash from investing is -$16.62B
- What is GSK TTM cash from investing most recent change?
- GSK TTM cash from investing was down -100.36% on September 30, 2026
- What is 1-year change in GSK TTM cash from investing?
- GSK TTM cash from investing is down -174.02% year-over-year
- How far is GSK TTM cash from investing from its all-time high?
- GSK TTM cash from investing is currently -278.15% below its historical high of $9.33B set on March 31, 2015
- How does GSK TTM cash from investing rank versus sector peers?
- GSK TTM cash from investing is higher than 0.29% of companies in Healthcare sector
- When is GSK next earnings release?
- The next earnings release for GSK is on
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
Data Sources & References
- GSK Official Website www.gsk.com
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk